{{Rsnum
|rsid=6704644
|Gene=USP40
|Chromosome=2
|position=233498009
|Orientation=plus
|GMAF=0.08724
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=USP40
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 74.3 | 23.9 | 1.8
| HCB | 94.9 | 5.1 | 0.0
| JPT | 79.6 | 18.6 | 1.8
| YRI | 87.8 | 12.2 | 0.0
| ASW | 86.0 | 12.3 | 1.8
| CHB | 94.9 | 5.1 | 0.0
| CHD | 93.6 | 6.4 | 0.0
| GIH | 75.2 | 20.8 | 4.0
| LWK | 80.9 | 19.1 | 0.0
| MEX | 75.9 | 24.1 | 0.0
| MKK | 78.8 | 20.5 | 0.6
| TSI | 77.5 | 21.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21646302
|Trait=None
|Title=Mayo genome consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.
|RiskAllele=
|Pval=8E-8
|OR=0.0760
|ORtxt=[0.05-0.11] mg/dL increase
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}